期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Mesenchymal stem cells therapy and COVID19:a narrative review
1
作者 Mohsen Ebrahimi Ali Ahmadi +1 位作者 Fatemeh Mohseni Mohammad Taha Saadati Rad 《Precision Medicine Research》 2021年第3期18-22,共5页
At the end of 2019,a new type of coronavirus pneumonia broke out in China and swept the world,and the World Health Organization named it COVID-19.Mesenchymal stem cells(MSCs)are cells with high differentiation potenti... At the end of 2019,a new type of coronavirus pneumonia broke out in China and swept the world,and the World Health Organization named it COVID-19.Mesenchymal stem cells(MSCs)are cells with high differentiation potential and their ability to regenerate.The therapeutic effects of mesenchymal stem cells are mediated by the secretion of various agents,including conventional secretory proteins such as cytokines and growth factors,as well as exosomes.MSC injection in patients with COVID-19 was found to have potent anti-inflammatory activity of mesenchymal stem cells.Such processes were evident from numerous beneficial outcomes,including an increase in peripheral lymphocyte counts,a decrease in C-reactive protein,and a decrease in active cytokine-secreting immune cells in the circulating blood for 3 to 6 days.It is suggested that due to the favorable results of studies in this field,more studies be done on this treatment method. 展开更多
关键词 COVID19 Mesenchymal stem cells(MSCs) PNEUMONIA
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部